Simplex Trading
SRNE

Simplex Trading’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Simplex Trading’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-19,500
Closed -$7K – 10472
2023
Q1 		$7K Sell
19,500
-12,900
-40% -$11.6K ﹤0.01% 7881
2022
Q4 		$28K Buy
32,400
+1,600
+5% +$2.12K ﹤0.01% 6565
2022
Q3 		$48K Sell
30,800
-39,000
-56% -$88.5K ﹤0.01% 6517
2022
Q2 		$140K Buy
69,800
+7,500
+12% +$13K ﹤0.01% 5094
2022
Q1 		$145K Sell
62,300
-88,300
-59% -$275K ﹤0.01% 5632
2021
Q4 		$700K Sell
150,600
-103,400
-41% -$642K ﹤0.01% 3363
2021
Q3 		$2.79M Buy
254,000
+56,200
+28% +$477K ﹤0.01% 1753
2021
Q2 		$1.92M Buy
+197,800
New +$1.58M ﹤0.01% 2219
2021
Q1 		– Sell
-3,306
Closed -$2.26M – 10401
2020
Q4 		$2.26M Sell
3,306
-908
-22% -$7.29K ﹤0.01% 1654
2020
Q3 		$4.7M Buy
4,214
+1,267
+43% +$11.6K 0.01% 910
2020
Q2 		$1.85M Buy
2,947
+1,919
+187% +$7.35K ﹤0.01% 1575
2020
Q1 		$189K Buy
1,028
+174
+20% +$501 ﹤0.01% 3667
2019
Q4 		$288K Buy
854
+182
+27% +$434 ﹤0.01% 3330
2019
Q3 		$143K Buy
672
+14
+2% +$33 ﹤0.01% 3930
2019
Q2 		$175K Buy
658
+163
+33% +$587 ﹤0.01% 3602
2019
Q1 		$235K Buy
+495
New +$1.3K ﹤0.01% 3428
2018
Q4 		– Sell
-766
Closed -$337K – 8082
2018
Q3 		$337K Buy
766
+389
+103% +$2.16K ﹤0.01% 3041
2018
Q2 		$271K Buy
377
+206
+120% +$1.4K ﹤0.01% 3134
2018
Q1 		$46K Buy
+171
New +$1.22K ﹤0.01% 2539
2017
Q2 		– Sell
-20
Closed -$2K – 7019
2017
Q1 		$2K Sell
20
-44
-69% -$221 ﹤0.01% 5402
2016
Q4 		$5K Buy
+64
New +$384 ﹤0.01% 4428
2016
Q1 		– Sell
-137
Closed -$38K – 6454
2015
Q4 		$38K Buy
137
+134
+4,467% +$1.13K ﹤0.01% 2150
2015
Q3 		$1K Buy
+3
New +$48 ﹤0.01% 5221
2015
Q2 		– Sell
-86
Closed -$9K – 6045
2015
Q1 		$9K Buy
+86
New +$995 ﹤0.01% 3052

Other funds holding SRNE

SW
SlateStone Wealth Jupiter, Florida $1.31B AUM 26.51% 1-Year Est. Return
KA
KLCM Advisors Milwaukee, Wisconsin $1.19B AUM 34.45% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return
OAJ
Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
CFGS
Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return

Simplex Trading's SRNE Position: Q4 2022 in Review

Simplex Trading sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2022, closing a stake of 147,289 shares — an estimated $195K sold.

Simplex Trading first reported a position in SRNE in Q1 2015 and held it in 11 quarters. The position peaked at $497K in Q2 2022. 223 funds tracked by Wall St. Rank hold SRNE as of Q4 2022.

  • Simplex Trading reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 147,289 Sorrento Therapeutics, Inc. shares in Q4 2022, an estimated $195K.
  • Simplex Trading first reported a position in Sorrento Therapeutics, Inc. in Q1 2015 and held it in 11 quarters.
  • Simplex Trading's Sorrento Therapeutics, Inc. position peaked at $497K in Q2 2022.
  • 223 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.